Biofrontera (BFRI) EPS (Weighted Average and Diluted) (2021 - 2025)

Biofrontera's EPS (Weighted Average and Diluted) history runs 5 years deep, the most recent figure standing at $0.63 for Q4 2025.

• In Q4 2025, EPS (Weighted Average and Diluted) rose 270.59% year-over-year to $0.63; the TTM figure through Dec 2025 stood at -$1.03 (up 72.46% YoY), while the FY2025 annual figure was -$1.04, up 67.7% from the prior year.
• EPS (Weighted Average and Diluted) was $0.63 for Q4 2025 at Biofrontera, up from -$0.62 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $4.55 in Q4 2023 to a low of -$7.23 in Q2 2023.
• Historically, EPS (Weighted Average and Diluted) has averaged -$1.1 across 5 years, with a median of -$0.57 in 2025.
• Biggest YoY gain for EPS (Weighted Average and Diluted) was 270.59% in 2025; the steepest drop was 1040.0% in 2025.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$2.0 in 2021, then sank by 40.0% to -$2.8 in 2022, then soared by 262.5% to $4.55 in 2023, then sank by 96.26% to $0.17 in 2024, then jumped by 270.59% to $0.63 in 2025.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.63 (Q4 2025), -$0.62 (Q3 2025), and -$0.57 (Q2 2025), per Business Quant data.